Florida Senate - 2013                        COMMITTEE AMENDMENT
       Bill No. SB 1448
       
       
       
       
       
       
                                Barcode 520342                          
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  03/20/2013           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Health Policy (Sobel) recommended the
       following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete lines 18 - 111
    4  and insert:
    5  Section 1. Paragraphs (h), (i), (j), (k), (l), (m), and (n) are
    6  added to subsection (3) of section 893.03, Florida Statutes, to
    7  read:
    8         893.03 Standards and schedules.—The substances enumerated
    9  in this section are controlled by this chapter. The controlled
   10  substances listed or to be listed in Schedules I, II, III, IV,
   11  and V are included by whatever official, common, usual,
   12  chemical, or trade name designated. The provisions of this
   13  section shall not be construed to include within any of the
   14  schedules contained in this section any excluded drugs listed
   15  within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
   16  Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
   17  Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
   18  Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
   19  Anabolic Steroid Products.”
   20         (3) SCHEDULE III.—A substance in Schedule III has a
   21  potential for abuse less than the substances contained in
   22  Schedules I and II and has a currently accepted medical use in
   23  treatment in the United States, and abuse of the substance may
   24  lead to moderate or low physical dependence or high
   25  psychological dependence or, in the case of anabolic steroids,
   26  may lead to physical damage. The following substances are
   27  controlled in Schedule III:
   28         (a) Unless specifically excepted or unless listed in
   29  another schedule, any material, compound, mixture, or
   30  preparation which contains any quantity of the following
   31  substances having a depressant or stimulant effect on the
   32  nervous system:
   33         1. Any substance which contains any quantity of a
   34  derivative of barbituric acid, including thiobarbituric acid, or
   35  any salt of a derivative of barbituric acid or thiobarbituric
   36  acid, including, but not limited to, butabarbital and
   37  butalbital.
   38         2. Benzphetamine.
   39         3. Chlorhexadol.
   40         4. Chlorphentermine.
   41         5. Clortermine.
   42         6. Lysergic acid.
   43         7. Lysergic acid amide.
   44         8. Methyprylon.
   45         9. Phendimetrazine.
   46         10. Sulfondiethylmethane.
   47         11. Sulfonethylmethane.
   48         12. Sulfonmethane.
   49         13. Tiletamine and zolazepam or any salt thereof.
   50         (b) Nalorphine.
   51         (c) Unless specifically excepted or unless listed in
   52  another schedule, any material, compound, mixture, or
   53  preparation containing limited quantities of any of the
   54  following controlled substances or any salts thereof:
   55         1. Not more than 1.8 grams of codeine per 100 milliliters
   56  or not more than 90 milligrams per dosage unit, with an equal or
   57  greater quantity of an isoquinoline alkaloid of opium.
   58         2. Not more than 1.8 grams of codeine per 100 milliliters
   59  or not more than 90 milligrams per dosage unit, with recognized
   60  therapeutic amounts of one or more active ingredients which are
   61  not controlled substances.
   62         3. Not more than 300 milligrams of hydrocodone per 100
   63  milliliters or not more than 15 milligrams per dosage unit, with
   64  a fourfold or greater quantity of an isoquinoline alkaloid of
   65  opium.
   66         4. Not more than 300 milligrams of hydrocodone per 100
   67  milliliters or not more than 15 milligrams per dosage unit, with
   68  recognized therapeutic amounts of one or more active ingredients
   69  that are not controlled substances.
   70         5. Not more than 1.8 grams of dihydrocodeine per 100
   71  milliliters or not more than 90 milligrams per dosage unit, with
   72  recognized therapeutic amounts of one or more active ingredients
   73  which are not controlled substances.
   74         6. Not more than 300 milligrams of ethylmorphine per 100
   75  milliliters or not more than 15 milligrams per dosage unit, with
   76  one or more active, nonnarcotic ingredients in recognized
   77  therapeutic amounts.
   78         7. Not more than 50 milligrams of morphine per 100
   79  milliliters or per 100 grams, with recognized therapeutic
   80  amounts of one or more active ingredients which are not
   81  controlled substances.
   82  
   83  For purposes of charging a person with a violation of s. 893.135
   84  involving any controlled substance described in subparagraph 3.
   85  or subparagraph 4., the controlled substance is a Schedule III
   86  controlled substance pursuant to this paragraph but the weight
   87  of the controlled substance per milliliters or per dosage unit
   88  is not relevant to the charging of a violation of s. 893.135.
   89  The weight of the controlled substance shall be determined
   90  pursuant to s. 893.135(6).
   91         (d) Anabolic steroids.
   92         1. The term “anabolic steroid” means any drug or hormonal
   93  substance, chemically and pharmacologically related to
   94  testosterone, other than estrogens, progestins, and
   95  corticosteroids, that promotes muscle growth and includes:
   96         a. Androsterone.
   97         b. Androsterone acetate.
   98         c. Boldenone.
   99         d. Boldenone acetate.
  100         e. Boldenone benzoate.
  101         f. Boldenone undecylenate.
  102         g. Chlorotestosterone (4-chlortestosterone).
  103         h. Clostebol.
  104         i. Dehydrochlormethyltestosterone.
  105         j. Dihydrotestosterone (4-dihydrotestosterone).
  106         k. Drostanolone.
  107         l. Ethylestrenol.
  108         m. Fluoxymesterone.
  109         n. Formebulone (formebolone).
  110         o. Mesterolone.
  111         p. Methandienone.
  112         q. Methandranone.
  113         r. Methandriol.
  114         s. Methandrostenolone.
  115         t. Methenolone.
  116         u. Methyltestosterone.
  117         v. Mibolerone.
  118         w. Nandrolone.
  119         x. Norethandrolone.
  120         y. Nortestosterone.
  121         z. Nortestosterone decanoate.
  122         aa. Nortestosterone phenylpropionate.
  123         bb. Nortestosterone propionate.
  124         cc. Oxandrolone.
  125         dd. Oxymesterone.
  126         ee. Oxymetholone.
  127         ff. Stanolone.
  128         gg. Stanozolol.
  129         hh. Testolactone.
  130         ii. Testosterone.
  131         jj. Testosterone acetate.
  132         kk. Testosterone benzoate.
  133         ll. Testosterone cypionate.
  134         mm. Testosterone decanoate.
  135         nn. Testosterone enanthate.
  136         oo. Testosterone isocaproate.
  137         pp. Testosterone oleate.
  138         qq. Testosterone phenylpropionate.
  139         rr. Testosterone propionate.
  140         ss. Testosterone undecanoate.
  141         tt. Trenbolone.
  142         uu. Trenbolone acetate.
  143         vv. Any salt, ester, or isomer of a drug or substance
  144  described or listed in this subparagraph if that salt, ester, or
  145  isomer promotes muscle growth.
  146         2. The term does not include an anabolic steroid that is
  147  expressly intended for administration through implants to cattle
  148  or other nonhuman species and that has been approved by the
  149  United States Secretary of Health and Human Services for such
  150  administration. However, any person who prescribes, dispenses,
  151  or distributes such a steroid for human use is considered to
  152  have prescribed, dispensed, or distributed an anabolic steroid
  153  within the meaning of this paragraph.
  154         (e) Ketamine, including any isomers, esters, ethers, salts,
  155  and salts of isomers, esters, and ethers, whenever the existence
  156  of such isomers, esters, ethers, and salts is possible within
  157  the specific chemical designation.
  158         (f) Dronabinol (synthetic THC) in sesame oil and
  159  encapsulated in a soft gelatin capsule in a drug product
  160  approved by the United States Food and Drug Administration.
  161         (g) Any drug product containing gamma-hydroxybutyric acid,
  162  including its salts, isomers, and salts of isomers, for which an
  163  application is approved under s. 505 of the Federal Food, Drug,
  164  and Cosmetic Act.
  165         (h) Human chorionic gonadotropin (hCG).
  166         (i) CJC-1295.
  167         (j) Growth hormone releasing hormone (GHRH).
  168         (k) Growth hormone releasing hexapeptide (GHRP-6).
  169         (l) Human growth hormone (HGH).
  170         (m) Somatropin.
  171         (n) Tesamorelin.
  172  
  173  
  174  ================= T I T L E  A M E N D M E N T ================
  175         And the title is amended as follows:
  176         Delete line 7
  177  and insert:
  178         performance; adding human chorionic gonadotropin to
  179         the list of Schedule III controlled substances;
  180         reenacting s. 893.12(1)-(6), F.S.,